Title
Removing Barriers to Tecovirimat for Mpox-infected Individuals via Novel Models of Care Delivery
Files
Download Full Text (895 KB)
Description
Problem Statement
During the 2022 mpox outbreak, the CDC’s expanded access Investigational New Drug (IND) protocol created a practical barrier to the outpatient provision of tecovirimat. We rapidly implemented a tecovirimat prescription program for individuals infected with mpox to improves access to care.
Project AIM
Primary aim: describe how we rapidly implemented a program for increasing tecovirimat distribution in a metropolitan area.
Secondary aims: describe the patient population who received tecovirimat as treatment for mpox at our clinic and analyze several clinically relevant time intervals along the continuum of care delivery.
Publication Date
5-1-2023
Keywords
mpox, disparities, tecovirimat, investigational new drug, IND, outbreak, infectious disease
Disciplines
Infectious Disease | Medicine and Health Sciences
Recommended Citation
McCarthy, BA, Michael; Glowacki, DO, MS, Joe; Livinsky, PA, Rostislav; Taupin, MD, MHQS, Daniel; and Coppock, MD. MSCE, Dagan, "Removing Barriers to Tecovirimat for Mpox-infected Individuals via Novel Models of Care Delivery" (2023). Division of Infectious Diseases and Environmental Medicine Posters. 5.
https://jdc.jefferson.edu/didemposters/5
Comments
Presented at the 2023 Health Equity and Quality Improvement Summit.